Prognosis in Heart Failure and the Value of β-Blockers Are Altered by the Use of Antidepressants and Depend on the Type of Antidepressants Used.

The article discusses the study which evaluates the kind of antidepressants use for patients with heart failure (HF) to increase survival rate in the U.S. It notes that guidelines for the recommendation of selective serotonin reuptake inhibitors (SSRIs) is necessary after its high rate of association in cardiovascular death. It reveals that the usage of antidepressant is associated with worse prognosis for patients with HF.